Global Regulators Outline Quality Expectations For Cell And Gene Therapy Raw Materials

 
• By Vibha Sharma

The International Pharmaceutical Regulators Programme explains how manufacturers of cell and gene therapy products can assess and mitigate the potential risks associated with product raw materials.

DNA
Cell And Gene Therapy products are sensitive to variations in the quality of raw materials • Source: Shutterstock

More from International

More from Geography